Background: Patients with rheumatic diseases are more likely to suffer from anxiety, depression and insomnia. Yet, little is known about mental health status during COVID-19 pandemic.
Objective: This study aims to measure the prevalence of mental health disorders among patients with rheumatic diseases in the era of COVID-19 pandemic and to determine potential risk factors for major symptoms of depression, anxiety, and insomnia in participants.
Background: People with rheumatic disease may be at higher risk for more severe course with COVID- 19, and the adverse effects of drugs used to treat rheumatic diseases is a major concern.
Objective: We conducted this survey to learn about the real impact of COVID-19 pandemic on patients with rheumatic diseases.
Methods: Participants were asked to complete a questionnaire using a telephonic interview conducted by two rheumatologists.